Needle-free transdermal delivery of mRNA vaccine with ionic liquid crystals and effective tumor growth inhibition
RSC Pharmaceutics · 2026 · 3 (3) · 659-668
DOI: 10.1039/d5pm00327j ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Tomohiro Higashi und 6 weiteren Autor:innen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Transdermal delivery of mRNA vaccine with ionic liquid crystal (ILC).
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Higashi, T., Tanaka, K., Toyofuku, K., Wakabayashi, R., Kawaguchi, Y., Kamiya, N., & Goto, M. (2026). Needle-free transdermal delivery of mRNA vaccine with ionic liquid crystals and effective tumor growth inhibition. RSC Pharmaceutics, 3(3), 659-668. https://doi.org/10.1039/d5pm00327j
Vancouver
Higashi T, Tanaka K, Toyofuku K, Wakabayashi R, Kawaguchi Y, Kamiya N, et al. Needle-free transdermal delivery of mRNA vaccine with ionic liquid crystals and effective tumor growth inhibition. RSC Pharmaceutics. 2026;3(3):659-668. doi:10.1039/d5pm00327j
BibTeX
@article{Higashi2026,
author = {Higashi, Tomohiro and Tanaka, Keisuke and Toyofuku, Kiyohiro and Wakabayashi, Rie and Kawaguchi, Yoshirou and Kamiya, Noriho and Goto, Masahiro},
title = {Needle-free transdermal delivery of mRNA vaccine with ionic liquid crystals and effective tumor growth inhibition},
journal = {RSC Pharmaceutics},
year = {2026},
volume = {3},
number = {3},
pages = {659--668},
doi = {10.1039/d5pm00327j}
}
EUVIMED